Gene Logic Names New CEO; Affy Adds Director; Transgenomic Loses Director; Codon Hires CFO; and Others | GenomeWeb
NEW YORK (GenomeWeb News) – Gene Logic this week named Charles Dimmler its new CEO. Dimmler replaces Mark Gessler, who will maintain his position as chairman of the board of directors.
Dimmler has been on Gene Logic’s board of directors for 10 years, and has involved in biotechnology management and finance for 20.

Affymetrix has named Robert Wayman to its board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.